Chris Robillard

Corporate Officer/Principal bei CRINETICS PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Aktive Positionen von Chris Robillard

Unternehmen	Position	Beginn	Ende
CRINETICS PHARMACEUTICALS, INC.	Corporate Officer/Principal	21.03.2022	-

Unternehmen	Position	Beginn	Ende
KARYOPHARM THERAPEUTICS INC.	Corporate Officer/Principal	-	-
Goldfinch Bio, Inc. Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-	-

Lehigh University	Undergraduate Degree
Pepperdine University	Masters Business Admin

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Undergraduate Degree	1
Masters Business Admin	1

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
CRINETICS PHARMACEUTICALS, INC.	Health Technology
KARYOPHARM THERAPEUTICS INC.	Health Technology

Private Unternehmen	1
Goldfinch Bio, Inc. Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA.	Health Technology

Private Unternehmen

Health Technology